Fytexia

Founded in 2003 and headquartered in France, Fytexia is a life science company specializing in the development of scientifically supported active nutrients and ingredients for the dietary supplement and healthcare industries. The company focuses on research, scientific validation, and the development of functional compounds, such as polyphenols, to deliver solutions that aim to reduce risk factors associated with non-communicable diseases. By collaborating with a global network of researchers, Fytexia characterizes active compounds and conducts clinical studies to demonstrate the efficacy of its proprietary ingredients, providing ready-to-use solutions to health supplement manufacturers worldwide. Fytexia is part of ABF Ingredients, a subsidiary of Associated British Foods, following its acquisition in 2022.

These ingredients are integrated into advanced healthcare products to support metabolic, immune, and digestive health, as well as healthy aging. By providing ingredients backed by clinical research and peer-reviewed articles, the company enables its customers—manufacturers in the nutrition industry—to create products that improve consumer health and well-being. Fytexia’s expertise in polyphenol-based extracts and its portfolio of proprietary ingredients position it as a key partner for companies seeking to innovate in the nutraceutical sector. Through its integration with ABF Ingredients and the broader Biotexia brand, the company continues to provide evidence-led nutritional solutions on a global scale.